Relmada Therapeutics Inc
F:4E2
Relmada Therapeutics Inc
F:4E2
Price:
6.5
EUR
6.56%
Market Closed
Market Cap:
€195.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
F:4E2
|
US |
|
C
|
Compagnie Generale des Etablissements Michelin SCA
F:MCH
|
FR |
|
Commerzbank AG
MIL:CBK
|
DE |
|
Persol Holdings Co Ltd
OTC:TEMPF
|
JP |
|
Sanofi SA
F:SNW
|
FR |
|
PSP Swiss Property AG
F:P7S
|
CH |
|
F
|
First Advantage Corp
F:0MS
|
US |
|
W
|
Willis Towers Watson PLC
XMUN:WTY
|
UK |
|
J
|
Jiangxi Copper Co Ltd
SWB:JIX
|
CN |
|
B
|
Baozun Inc
XMUN:2BZA
|
CN |
|
C
|
Cadence Design Systems Inc
XMUN:CDS
|
US |
|
SKF AB
F:SKFA
|
SE |
|
Coca Cola HBC AG
F:CCKC
|
CH |
|
Plazza AG
F:2PZ
|
CH |
|
E
|
Experian PLC
F:J2B
|
IE |
|
Compagnie du Cambodge SA
F:7IW0
|
FR |
|
N
|
NP3 Fastigheter AB
F:N33
|
SE |
|
C
|
Camden Property Trust
F:CAL
|
US |
|
Corporacion Acciona Energias Renovables SA
F:5BP
|
ES |
|
A
|
Advanced Micro Devices Inc
XHAM:AMD
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of Relmada Therapeutics Inc.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Not Available
